With that in mind, the 13th annual Immunogenicity for Biotherapeutics conference is pleased to invite you to enroll in “Immunogenicity University,” a unique and in-depth interactive learning opportunity. We’ve devoted an entire day to helping you cooperatively strengthen your analytical methods, in a setting that will make sure everyone is on the same page for the much more novel and detailed case studies to be explored throughout the rest of our event.
Immunogenicity University Highlights:
- - Fundamentals of Immunogenicity Assessment from Ambrx & Amylin Pharmaceuticals
- - Trusting your Data Chain: Assay Transferability From Pfizer
- - Intensive Skill-Builder for Statistical Analysis from Human Genome Sciences and Medimmune
- - Plan for Challenges in Clinical and Non-Clinical Development of Anti-Therapeutic Antibody Assays From Genentech & GlaxoSmithKline
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment